Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Brain Cancers”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01986348
What this trial is testing

Study Evaluating the Efficacy and Safety of Selinexor (KPT-330) in Participants With Recurrent Gliomas

Who this might be right for
GlioblastomaGlioma
Karyopharm Therapeutics Inc 76
Post-approval studies (Phase 4)Study completedNCT01794793
What this trial is testing

Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies

Who this might be right for
Cushing's DiseaseAcromegalyNeuroendocrine Tumors+6 more
RECORDATI GROUP 337
Not applicableStudy completedNCT00010114
What this trial is testing

Genetic Study of Newly Diagnosed Central Nervous System Tumors in Young Children

Who this might be right for
Central Nervous System Embryonal Neoplasm
Pediatric Brain Tumor Consortium 83
Testing effectiveness (Phase 2)Study completedNCT00423852
What this trial is testing

Paclitaxel, Ifosfamide, and Carboplatin Followed By Autologous Stem Cell Transplant in Treating Patients With Germ Cell Tumors That Did Not Respond to Cisplatin

Who this might be right for
Brain and Central Nervous System TumorsExtragonadal Germ Cell TumorOvarian Cancer+2 more
Memorial Sloan Kettering Cancer Center 26
Testing effectiveness (Phase 2)Study completedNCT00331526
What this trial is testing

Cellular Adoptive Immunotherapy in Treating Patients With Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Hoag Memorial Hospital Presbyterian 83
Not applicableNot Yet RecruitingNCT07704034
What this trial is testing

Wearable-Triggered Digital Safety Net for Real-Time Monitoring & Intervention in Leptomeningeal Metastasis

Who this might be right for
Leptomeningeal Metastasis
Case Comprehensive Cancer Center 48
Testing effectiveness (Phase 2)Study completedNCT00038493
What this trial is testing

Temozolomide and SCH66336 for Recurrent Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
M.D. Anderson Cancer Center 23
Testing effectiveness (Phase 2)Study completedNCT00817284
What this trial is testing

Bevacizumab and Irinotecan or Bevacizumab and Temozolomide With Concomitant Radiotherapy for Primary Glioblastoma Multiforme (GBM)

Who this might be right for
Glioblastoma Multiforme
Ulrik Lassen 60
Post-approval studies (Phase 4)UnknownNCT02929147
What this trial is testing

Comparison of Efficacy and Safety of the Postoperative Analgesia Methods

Who this might be right for
Supratentorial Neoplasms
Istanbul University 90
Testing effectiveness (Phase 2)Study completedNCT03668847
What this trial is testing

DM-CHOC-PEN for Brain Tumors in AYA Subjects

Who this might be right for
Advanced CancerBrain Metastases
DEKK-TEC, Inc. 20
Early research (Phase 1)WithdrawnNCT03177252
What this trial is testing

Scalp Block: Hemodynamic Stability and Patient Comfort In Craniotomy Patients

Who this might be right for
Tumor, BrainAnesthesia, Local
Washington University School of Medicine
Testing effectiveness (Phase 2)Active Not RecruitingNCT05630209
What this trial is testing

Blood Brain Barrier (BBB) Disruption Using Exablate Focused Ultrasound With Doxorubicin for Treatment of Pediatric Diffuse Intrinsic Pontine Gliomas (DIPG)

Who this might be right for
Brain Tumor
InSightec 10
Not applicableStudy completedNCT00136032
What this trial is testing

Growth Hormone Administration and Its Effects on Cardiovascular Risk Factors in Growth Hormone Deficient Women

Who this might be right for
Growth Hormone Deficiency
Massachusetts General Hospital 63
Testing effectiveness (Phase 2)Ended earlyNCT00638963
What this trial is testing

Temozolomide as a Prophylaxis Against Brain Recurrence in Participants With Metastatic Breast Cancer (P05225 AM2)

Who this might be right for
Breast NeoplasmBrain NeoplasmSecond Neoplasm
Merck Sharp & Dohme LLC 6
Not applicableStudy completedNCT05102201
What this trial is testing

Effect of the Group-based Paro Intervention on Physiological and Psychological Outcomes

Who this might be right for
Dementia, MildDementia ModerateCognitive Impairment
National Tainan Junior College of Nursing 118
Early research (Phase 1)Looking for participantsNCT06673329
What this trial is testing

Brodalumab in the Treatment of Immune-Related Adverse Events

Who this might be right for
Breast CancerEsophageal CancerKidney Cancer+15 more
Brian Henick, MD 11
Testing effectiveness (Phase 2)Study completedNCT03665545
What this trial is testing

Pembrolizumab in Association With the IMA950/Poly-ICLC for Relapsing Glioblastoma

Who this might be right for
Glioblastoma MultiformeGlioblastoma, AdultGlioma of Brain+1 more
University Hospital, Geneva 18
Not applicableStudy completedNCT00178295
What this trial is testing

Radiation-Induced Cytokine Cascades and Their Correlation With Central Nervous System Injury

Who this might be right for
Brain Neoplasm
University of Rochester 44
Testing effectiveness (Phase 2)Study completedNCT00003573
What this trial is testing

Etoposide Plus Radiation Therapy Followed by Combination Chemotherapy in Treating Children With Newly Diagnosed Advanced Medulloblastoma

Who this might be right for
Brain TumorsCentral Nervous System Tumors
Children's Oncology Group 53
Not applicableStudy completedNCT05321212
What this trial is testing

Efficacy and Safety of PEMbrolizumab PD-L1-positive (>50% of Tumor Cells), Advanced NSCL Cancer(PEMBREIZH)

Who this might be right for
Carcinoma, Non-Small-Cell LungImmunotherapy
University Hospital, Brest 108
Next Page